Senators cite study showing 22 times higher serious side effects from chemical abortion drugs than FDA labels indicate, ...
UniQure shares soared on positive AMT-130 Huntington's disease data, but plunged after the FDA reversed its stance on ...
3don MSN
'We don’t have time': Parents of 4-year-old with rare disorder urge FDA to reconsider drug denial
The FDA denied approving DCA to treat a rare disorder called PDCD. The Higbees are urging the agency to reconsider.
TipRanks on MSN
FDA Opens the Door for AI in Clinics, Priming Market for $2.7T Digital Health Wave by 2035
Vancouver, Canada, November 4th, 2025, FinanceWire USA News Group News Commentary – Healthcare’s embrace of AI is moving from pilot to ...
The Food and Drug Administration’s recent approval of a second generic version of the abortion pill mifepristone has left people on both sides of the reproductive rights fight scrambling to interpret ...
The US Food and Drug Administration said Friday that it is taking action to restrict the use of prescription fluoride supplements, following a directive from the government’s Make American Healthy ...
In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...
A 26% decline in drug overdose deaths from 2023 to 2024 is being credited by Minnesota leaders to investments that expanded ...
Somehow, it’s becoming even harder to get a GLP-1.
The U.S. Food and Drug Administration (FDA) has approved two new biosimilars as reference products for Prolia (denosumab) and XGEVA® (denosumab): Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo ...
The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from ...
Let’s be clear: 7-OH is not a public health crisis. According to the Food and Drug Administration’s (FDA) own Adverse Event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback